SLTL Medical to Showcase Next-Generation Cardiac Stents at SOLACI-SOCIME 2025 in Mexico

SLTL Medical, a division of the global community SLTL Group, is delighted to announce that it will be a part of the esteemed SOLACI-SOCIME 2025, one of the featured events in interventional cardiology in Latin America. From August 6 to August 8, 2025, at Expo Santa Fe, Mexico, cardiologists, medical professionals, and health care practitioners are invited to their booth No. 19 to learn about the company’s expanded innovations in cardiovascular engineering.

SOLACI-SOCIME is a well-known international congress developed by the Latin American Society of Interventional Cardiology (SOLACI) and the Mexican Society of Interventional Cardiology (SOCIME). It operates as an exchange of information for thought leaders, interventional cardiologists, vascular surgeons, clinical researchers, etc., on their new technologies, treatments, and to move interventional cardiology into the future. We at SLTL Medical are excited to be part of this event and showcase our contribution to improving cardiac care through precision engineering and medical innovation.

At this year’s trade show, SLTL Medical will be presenting its most advanced range of cardiac stents developed with advanced technology and the goal of better clinical outcomes. These stents have been years in the making and tested through extensive research and collaboration with medical experts. The stents have been developed with enhanced deliverability, biocompatibility, and overall long-term patient safety. Each product represents SLTL Medical’s commitment to providing state-of-the-art, minimally invasive solutions that meet the standards of modern cardiovascular treatment.

The exhibit will highlight next-generation drug-eluting and bare-metal stents, designed to provide optimal radial strength, flexibility, and minimize rates of restenosis. These products will allow for higher levels of surface finishing, micro-precision, and controlled drug rates enabling better heal responses and procedural success. Medical professionals attending SOLACI-SOCIME 2025 will have the opportunity to experience how SLTL Medical’s innovations overcome complex cardiac challenges, while facilitating ease of deployment during interventions.

Aside from product displays, SLTL Medical’s whole team of experts (biomedical engineers, product specialists, and clinical advisors) will be present throughout the event. They will conduct live product demonstrations, offer technical consultations, and hold case-based discussions to help health care professionals understand the performance and clinical applications of its solutions. This interactive setup is meant for shared learning, allowing clinicians to make educated choices that ultimately support patient care.

SLTL Medical’s participation in SOLACI-SOCIME 2025 emphasizes its vision of providing accessible, innovative, and effective cardiovascular treatment options to patients around the globe. The company believes that innovation, precision, and collaboration are crucial in addressing the challenges of healthcare today. As part of its mission, SLTL Medical’s presence will always be about establishing long-term relationships with medical institutions, doctors, and leaders in health care systems across Latin America and the world.

Meet SLTL Medical and their team at Booth No. 19 and take advantage of the opportunity to learn more about SLTL Medical’s stent technologies and discuss how future-ready engineering is helping to transform the landscape of interventional cardiology at a global scale in light of the rising incidence of cardiovascular conditions, accompanied by increased demands for minimally-invasive procedures. SLTL Medical is helping to provide solutions for better health outcomes recognized around the world.

Founded in 1989, SLTL Group (Sahajanand Laser Technology Ltd.) is a world-class technology and service provider in laser systems, medical device manufacturing, and intelligent automation. Headquartered in Gandhinagar, Gujarat, India, SLTL Group operates in over 38 countries. It is recognized for its commitment to precision engineering and research, development and industrial sector solutions. The medical division of SLTL Group, SLTL Medical, is an internationally recognized leader in designing and developing leading-edge medical technologies, including cardiac stents and micromachined critical care healthcare components. SLTL Medical holds firmly to the vision; Transforming Lives through Innovation. Developing compliant innovative solutions with scientific rigor and engineering excellence used to better the quality of human life and improve healthcare standards worldwide. To learn more about SOLACI-SOCIME 2025, visit https://www.sltl.com/event/solaci-socime-2025/

For media requests, product demonstrations, or to arrange a meeting with SLTL Medical during SOLACI-SOCIME 2025, kindly contact us at:
Company: SLTL Medical (a division of SLTL Group)
Email: [email protected]
Phone: +91 9925036495

Website:www.SLTLmedical.com